PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 168 filers reported holding PTC THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830 | +121.9% | 17,357 | +88.7% | 0.00% | 0.0% |
| Q2 2023 | $374 | -16.1% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $446 | +27.1% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $351 | -99.9% | 9,200 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $462,000 | +25.2% | 9,200 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $369,000 | +7.6% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $343,000 | -6.3% | 9,200 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $366,000 | +7.0% | 9,200 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $342,000 | -12.1% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $389,000 | -10.8% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $436,000 | -22.3% | 9,200 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $561,000 | +30.5% | 9,200 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $430,000 | -7.9% | 9,200 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $467,000 | +13.9% | 9,200 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $410,000 | +6.5% | 9,200 | +14.7% | 0.00% | +50.0% |
| Q4 2019 | $385,000 | +42.1% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $271,000 | -24.9% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $361,000 | +19.5% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $302,000 | +9.8% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $275,000 | -27.1% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $377,000 | +39.6% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $270,000 | +24.4% | 8,019 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $217,000 | +61.9% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $134,000 | -16.2% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $160,000 | +8.8% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $147,000 | +86.1% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $79,000 | -9.2% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $87,000 | -22.3% | 8,019 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $112,000 | +100.0% | 8,019 | 0.0% | 0.00% | – |
| Q2 2016 | $56,000 | +7.7% | 8,019 | 0.0% | 0.00% | – |
| Q1 2016 | $52,000 | -67.5% | 8,019 | +62.8% | 0.00% | -100.0% |
| Q4 2015 | $160,000 | +21.2% | 4,926 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $132,000 | -44.3% | 4,926 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $237,000 | – | 4,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |